Barry Johns

449 total citations
5 papers, 46 citations indexed

About

Barry Johns is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Oncology. According to data from OpenAlex, Barry Johns has authored 5 papers receiving a total of 46 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Endocrinology, Diabetes and Metabolism and 2 papers in Oncology. Recurrent topics in Barry Johns's work include Diabetes, Cardiovascular Risks, and Lipoproteins (2 papers), Cutaneous Melanoma Detection and Management (2 papers) and Metabolism, Diabetes, and Cancer (2 papers). Barry Johns is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (2 papers), Cutaneous Melanoma Detection and Management (2 papers) and Metabolism, Diabetes, and Cancer (2 papers). Barry Johns collaborates with scholars based in United States. Barry Johns's co-authors include Alan C. Pao, Sun H. Kim, Gerald M. Reaven, Fahim Abbasi, Carl V. Washington, Emir Veledar, Suephy C. Chen and David H. Lawson and has published in prestigious journals such as Clinical Chemistry, Nephrology Dialysis Transplantation and Dermatologic Surgery.

In The Last Decade

Barry Johns

4 papers receiving 45 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Barry Johns United States	3	24	18	14	7	5	5	46
Wen‐Hong L. Kao United States	2	12 0.5×	6 0.3×	7 0.5×	8 1.1×	8 1.6×	3	32
Balaji Rajagopalan India	4	18 0.8×	6 0.3×	4 0.3×	4 0.6×	2 0.4×	10	32
Г. И. Фурменко Russia	3	9 0.4×	13 0.7×	36 2.6×	8 1.1×	9 1.8×	6	53
Leorino Sobrepeña Hong Kong	3	58 2.4×	14 0.8×	3 0.2×	5 0.7×	10 2.0×	3	64
Anushree Tiku Australia	2	6 0.3×	4 0.2×	12 0.9×	2 0.3×	5 1.0×	2	24
Isabel Correia Brazil	3	16 0.7×	24 1.3×	2 0.1×	23 3.3×	10 2.0×	5	54
B. Krtalic Croatia	3	9 0.4×	4 0.2×	8 0.6×	14 2.0×	9 1.8×	7	53
Serena Pelusi Italy	4	23 1.0×	59 3.3×	2 0.1×	8 1.1×	10 2.0×	11	79
Sara Mazzocut Italy	3	75 3.1×	4 0.2×	22 1.6×	28 4.0×	9 1.8×	3	103
Victor Razuk United States	3	19 0.8×	20 1.1×	2 0.1×	7 1.0×	9 1.8×	9	47

Countries citing papers authored by Barry Johns

Since Specialization

Citations

This map shows the geographic impact of Barry Johns's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barry Johns with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barry Johns more than expected).

Fields of papers citing papers by Barry Johns

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barry Johns. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barry Johns. The network helps show where Barry Johns may publish in the future.

Co-authorship network of co-authors of Barry Johns

This figure shows the co-authorship network connecting the top 25 collaborators of Barry Johns. A scholar is included among the top collaborators of Barry Johns based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barry Johns. Barry Johns is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Johns, Barry, Alan C. Pao, & Sun H. Kim. (2011). Metabolic syndrome, insulin resistance and kidney function in non-diabetic individuals. Nephrology Dialysis Transplantation. 27(4). 1410–1415. 33 indexed citations

2.

Johns, Barry, Fahim Abbasi, & Gerald M. Reaven. (2011). Estimates of Insulin Secretory Function in Apparently Healthy Volunteers Vary as a Function of How the Relevant Variables Are Quantified. Clinical Chemistry. 57(4). 627–632. 7 indexed citations

3.

Johns, Barry & Gerald M. Reaven. (2010). PPAR-γ agonists, insulin resistance and dyslipidemia: not a simple relationship. Clinical Lipidology. 5(4). 509–525. 5 indexed citations

4.

Lawson, David H., et al.. (2007). Interferon Alfa-2b or Not 2b? Significant Differences Exist in the Decision-Making Process between Melanoma Patients Who Accept or Decline High-Dose Adjuvant Interferon Alfa-2b Treatment. Dermatologic Surgery. 33(1). 11–16. 1 indexed citations

5.

Lawson, David H., et al.. (2007). Interferon Alfa-2b or Not 2b? Significant Differences Exist in the Decision-Making Process between Melanoma Patients Who Accept or Decline High-Dose Adjuvant Interferon Alfa-2b Treatment. Dermatologic Surgery. 33(1). 11–16.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact